↓ Skip to main content

Erythropoietin as an adjuvant treatment with (chemo) radiation therapy for head and neck cancer

Overview of attention for article published in Cochrane database of systematic reviews, July 2009
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (80th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (54th percentile)

Mentioned by

twitter
5 tweeters
wikipedia
1 Wikipedia page

Citations

dimensions_citation
63 Dimensions

Readers on

mendeley
72 Mendeley
citeulike
1 CiteULike
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Erythropoietin as an adjuvant treatment with (chemo) radiation therapy for head and neck cancer
Published in
Cochrane database of systematic reviews, July 2009
DOI 10.1002/14651858.cd006158.pub2
Pubmed ID
Authors

Philippe Lambin, Bram LT Ramaekers, Ghislaine APG van Mastrigt, P Van den Ende, J de Jong, Dirk K M De Ruysscher, Madelon Pijls-Johannesma

Abstract

Tumour hypoxia increases tumour invasiveness and has a negative impact on response to therapy. Hypoxic tumours are also associated with severely anaemic individuals. It has therefore been hypothesised that correcting anaemia, by increasing haemoglobin levels using erythropoietin, improves tumour oxygenation and consequently the patient's prognosis.

Twitter Demographics

The data shown below were collected from the profiles of 5 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 72 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 1%
Unknown 71 99%

Demographic breakdown

Readers by professional status Count As %
Student > Master 13 18%
Student > Ph. D. Student 9 13%
Researcher 8 11%
Lecturer 5 7%
Other 5 7%
Other 20 28%
Unknown 12 17%
Readers by discipline Count As %
Medicine and Dentistry 44 61%
Agricultural and Biological Sciences 4 6%
Nursing and Health Professions 4 6%
Pharmacology, Toxicology and Pharmaceutical Science 2 3%
Psychology 1 1%
Other 4 6%
Unknown 13 18%

Attention Score in Context

This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 31 January 2020.
All research outputs
#3,305,470
of 16,726,235 outputs
Outputs from Cochrane database of systematic reviews
#6,086
of 11,580 outputs
Outputs of similar age
#31,404
of 159,457 outputs
Outputs of similar age from Cochrane database of systematic reviews
#32
of 68 outputs
Altmetric has tracked 16,726,235 research outputs across all sources so far. Compared to these this one has done well and is in the 80th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,580 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 24.4. This one is in the 47th percentile – i.e., 47% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 159,457 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 80% of its contemporaries.
We're also able to compare this research output to 68 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 54% of its contemporaries.